Cost-Effectiveness Analysis of Rifaximin-Α Administration for the Reduction of the Overt Hepatic Encephalopathy Episodes in Recurrence in France

Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.966
https://www.valueinhealthjournal.com/article/S1098-3015(16)32332-4/fulltext
Section Title : Disease-Specific Studies
Section Order : 906
First Page : A513
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32332-4&doi=10.1016/j.jval.2016.09.966
HEOR Topics :
Tags :
Regions :